Efpia - European Federation Of Pharmaceutical Industries And Associations company information, Employees & Contact Information

EU-US trade deal leaves EFPIA’s lead “concerned for the future” Pharmaceutical Technology

Newly proposed EU drug regulations a 'missed opportunity' to support innovation, industry says Fierce Pharma

Pharma industry calls EU pharma package counterproductive European Biotechnology Magazine

EFPIA Criticizes EU Council’s Pharma Package Decision as Setback for Innovation NAVLIN DAILY

Improving equitable access to medicines in Europe must remain a priority The Parliament Magazine

Trump Tariffs Loom—But Pharma Warns EU: Don’t Retaliate The European Conservative

US and EU confirm tariff deal on pharmaceuticals, generics largely exempt European Biotechnology Magazine

Advancing the Precision Oncology Agenda in Europe PharmTech

EFPIA: EU pharma manufacturing would ‘grind to a halt’ under proposed PFAS ban Regulatory Affairs Professionals Society | RAPS

Maintaining a Competitive Edge: Building a Resilient European Health System The Parliament Magazine

Europe needs to go back on the map, says EFPIA Clinical Trials Arena

Pharma group backs EU efforts to assist life science sector, but urges bigger push FirstWord Pharma

Revisiting the Landscape of Potential Small and Drug Substance Related Nitrosamines in Pharmaceuticals ScienceDirect.com

Tackling disparities in cancer care across Europe: how can we improve access for all patients in Europe? Oncology Central

European pharma companies warn Trump's tariffs could expedite shift to US Reuters

The Spanish AEPD Publishes Statement on the Interplay Between its Code of Conduct for the Pharmaceutical Industry and the Potential EU Code of Conduct on Clinical Trials Inside Privacy

UPDATE: With looming Trump tariffs, pharma companies demand changes to stay in EU Fierce Pharma

The time is now: Combatting Antimicrobial Resistance with Transferable Exclusivity Vouchers The Parliament Magazine

UPDATED: Trump locks in 15% pharmaceutical tariff rate for EU, while generic drugs get a pass Fierce Pharma

Investing in healthy societies by boosting biotech competitiveness The Parliament Magazine

CSL Joins EFPIA, the Leading Voice of the Biotech Industry in Europe Global Biotechnology Company

A 10-year update to the principles for clinical trial data sharing by pharmaceutical companies: perspectives based on a decade of literature and policies BMC Medicine

EFPIA report highlights persistent access gaps for new medicines in Europe The Pharma Letter

EFPIA reaction to European Parliament plenary vote European Pharmaceutical Review

Proposed chemical ban would cause EU drug manufacturing to 'grind to a halt,' trade group warns Fierce Pharma

EFPIA Warns EU’s Role in Innovation Is in Jeopardy NAVLIN DAILY

EU pharma chief calls for European Nasdaq to boost biotech innovation Euronews.com

The research-based industry response to COVID-19; collaboration and innovation European Pharmaceutical Review

European Union: Long-awaited Social Media Guidance issued by EFPIA and IFPMA Global Compliance News

Drug firms finance Europe’s patient groups with multi-million donations Investigate Europe

EU pharmaceutical industry's ultimatum to von der Leyen: "With tariffs, increasing reasons to move to the US" Eunews

Novo Nordisk CEO sounds alarm on EU reform for cheaper medicines medwatch.com

The shake-up of orphan and pediatric rules politico.eu

EU Biotech Act: Have your say! European Biotechnology Magazine

EARA/EFPIA response to antibody recommendation European Animal Research Association

Industrial policy and what it means for the healthcare sector The Parliament Magazine

Pharma industry gives 'stark warning' to von der Leyen over Trump tariffs Euractiv

Nitrosamines: the beginning of the end? European Pharmaceutical Review

ARM, EFPIA and EuropaBio Call for Advanced Therapies to be Exempt from EU GMO Legislation GlobeNewswire

EFPIA Statement on the use of AI Cuatrecasas

A massive diabetes challenge and pharma-tech moonshots, Europe starts 2025 in launch mode Euractiv

New IFPMA and EFPIA guidance on use of social media by the pharmaceutical industry pharmaphorum

The pharmaceutical industry in Europe Open Access Government

Europe's pharmaceutical giants warn EU chiefs of 'exodus' to the US over Trump tariffs Daily Mail

Beating cancer in Europe: A health priority within our grasp Euractiv

MHP wins EFPIA account for EU health outcomes campaign PMLiVE

Jim Murray: New fronts in the struggle for transparency BMJ Blogs